KQ Labs’ Post

#top50familyoffices the strüngmann twins' investment in BioNTech SE proves the transformative power of "old money" for the startup ecosystem. their investment not only accelerated BioNTech's COVID-19 vaccine but showcases the pivotal role which family offices can play, in bridging the gap from research to startups which become European tech champions. if you are interested in the topic, I can highly recommend Mark Boeschen‘s article about the 50 largest #familyoffices in Germany (link in the comments). If you are a founder with ambitions to build another European tech champion, reach out to us at DTCF | DeepTech & Climate Fonds

We're thrilled to announce that Legal-Pythia has been named one of the top 50 startups to watch in the Glasgow City Region! 🚀 This recognition is a powerful validation of our mission to revolutionize legal operations through AI. We're honored to be included among the most promising companies in the region. Let's continue to push the boundaries of legal tech together! #LegalTech #Startup #Glasgow #Innovation #AI #LegalPythia #FinTech #ExplainableAI #Financials #FinancialServices #FraudDetection #documentautomation #ukstartup #legalindustry

Loyal, the groundbreaking biotech company founded by Celine Halioua , is on a mission to help dogs live longer, healthier lives with their pioneering longevity drugs. In a candid conversation, Celine shared her insights and lessons learned on this challenging journey: - The importance of building from scratch and learning from failure 💡 - Navigating FDA approval while sizing up new markets 📈 - Understanding the biggest mistakes founders can make 🤔 - Why biotech startups need to rethink fundraising strategies 💰 - And how Silicon Valley can accelerate deep tech innovation 🌐 It's a story of unwavering determination, vision, and the courage to tackle the toughest problems in biotech. Check out the full conversation for a deep dive into Loyal’s path to redefine the future of longevity! 📣 Celine from Loyal - https://lnkd.in/gM4nUcjD

🌟 Memorable Moments at the BoldBrain Startup Challenge Final of 07.12.2023🌟 🚀 On this day, I had the opportunity to present myDoctorAngel. Standing in front of a large audience, I pitched our vision directly from a box – a symbolic gesture of thinking outside the conventional bounds. 💡 The inspiration behind myDoctorAngel stems from a poignant reality: the untimely loss of many due to drug toxicity and disease complications in oncology. This realization sparked in me a profound need to innovate, to devise solutions that could potentially save millions of lives in the future. 🩺 myDoctorAngel is more than just a startup; it's a revolution in patient care. Our mission transcends traditional approaches, focusing on the patient's quality of life, advocating for change, and embracing technology as our ally in this journey. 🤝 We're looking for passionate individuals to join our team and our network. Together, we can make a significant impact. Join us in our endeavor to save millions of lives through innovative technology. #myDoctorAngel #InnovationInHealthcare #StartupPitch #PatientCare #TechnologyForGood #JoinOurMission #Boldbrain

Congrats to Vivalyx, an innovative Organ Vitality Tech startup based in Aachen, on successfully closing an oversubscribed seed funding round, raising above EUR 5 million. Investors include leading European Life Science and Deeptech venture capital firms such as Brightlands Venture Partners, TechVision Fonds, Arve Capital, the American Deeptech VC Goose Capital, and notable private angel investors.   The funding enables Vivalyx to finance the clinical study required for regulatory approval. This crucial step paves the way for the launch of the innovative organ preservation solution, which has the potential to extend the lifespan of donor organs and enhance their vitality. Vivalyx technology aims to significantly increase the number of organs available for transplantation, thus saving and improving the lives of patients worldwide – at significantly lower costs, considerably reduced complexity, and streamlined processes.   Thumbs up also to the international Orrick team including Ilona Schütz, David Hamala, Sven Greulich, Benedikt Migdal and further colleagues.   Orrick, Herrington & Sutcliffe LLP #medtech #lifesciences #organdonation #venturecapital #founders #innovation #TeamOrrick

Excited to announce a new adventure. What if you could guarantee translation from bench to bedside by testing on humans before clinical trials? What if your experiments yielded pristine, high-resolution, high-content, multi-modal human data with perfect reproducibility? What if you had enough throughput to try any human dosing regimen or permutation of combination therapy? What if you had automated analysis and visualization of results? Automated optimization of experimental design? Automated prediction of human endpoints? If you want to live in that world, I encourage you to check out Vivodyne. I’m stoked to join an exceptional group of people to accelerate the successful discovery, design, and development of therapeutics through novel #biology, #robotics, and applied #AI.

🌟 Memorable Moments at the BoldBrain Startup Challenge Final of 07.12.2023🌟 🚀 On this day, I had the opportunity to present myDoctorAngel. Standing in front of a large audience, I pitched our vision directly from a box – a symbolic gesture of thinking outside the conventional bounds. 💡 The inspiration behind myDoctorAngel stems from a poignant reality: the untimely loss of many due to drug toxicity and disease complications in oncology. This realization sparked in me a profound need to innovate, to devise solutions that could potentially save millions of lives in the future. 🩺 myDoctorAngel is more than just a startup; it's a revolution in patient care. Our mission transcends traditional approaches, focusing on the patient's quality of life, advocating for change, and embracing technology as our ally in this journey. 🤝 We're looking for passionate individuals to join our team and our network. Together, we can make a significant impact. Join us in our endeavor to save millions of lives through innovative technology. #myDoctorAngel #InnovationInHealthcare #StartupPitch #PatientCare #TechnologyForGood #JoinOurMission #Boldbrain

Such great news for the biotech and life sciences start-up space in Europe! From Goldman Sachs' first Life Sciences VC Fund to Earlybird's Health Tech fund, these achievements demonstrate the industry's recognition of the importance of private companies in the health tech sector, which can help address the shortcomings of the public healthcare system and drive innovation. I am more than thrilled to witness the potential impact these start-ups can have in revolutionizing the healthcare industry! E11evate #venturecapital #venturestudio #healthtech #biotech #medtech

IgniteData has successfully closed its fully subscribed $8 million seed round. This round was led by SpringTide Ventures, who has joined the IgniteData board alongside existing strategic investor, ZS. SpringTide’s co-investors are Oncology Ventures and Frank Naeymi-Rad, co-founder of Intelligent Medical Objects, Inc. and a Chairman of Leap of Faith Technologies, Inc. In addition to the new coalition of investors, IgniteData received further backing from Innovate UK in the form of an additional grant and R&D loan. The funding will enhance IgniteData’s ability to scale at an accelerated pace to meet growing demand from leading research sites and sponsors, while expanding the company’s product suite. $8 million seed investment round turbocharges IgniteData’s growth - read full news release here: https://lnkd.in/eJgvarR2 Ryan Morley Ben Freeberg Frank Naeymi-Rad Zach Taft, MBA #innovation #growth #healthtech #interoperability #clinicaltrials

🚀 We're super excited to share that Q Bio has closed a $27 million strategic funding round, and we are thrilled to be part of this journey. This investment is set to turbocharge their mission of making preventive healthcare accessible and affordable for everyone. Joining the amazing existing investors at a16z Bio + Health, Founders Fund and Khosla Ventures we are proud to lead this round. Why We’re Backing Q Bio: 🔍 All-In-One Health Check: Q Bio combines whole-body MRI scans with urine and blood tests, biomarkers, and your genetic & medical history to create a super detailed #digitaltwin profile. This helps catch health issues early and keep you on top of your game. 🏥 Three Game-Changing Tech Pillars: - Gemini Software: Integrates with any 3rd party MRI machines to give you clear exam summaries and risk assessments. - Mark I Full Body Scanner: This scanner can do a full-body check in just 10 minutes without the usual claustrophobia or radiation worries. Significant leap from the traditional MRI tech. - Anatomical Foundation Model (AFM): Uses AI to detect any anomalies, helping radiologists focus only on what needs a closer look. Tackling the Big Challenges: 💡 Cutting Costs, Boosting Efficiency: Q Bio's tech makes preventive health scans cheaper and faster. The Mark I scanner is low maintenance and high throughput, cutting down on costs and making multiple scans feasible, reducing false positives. Looking Ahead: This funding is all about making advanced health scans more accessible. We're thrilled to partner with Q Bio and help drive better health outcomes on a large scale. Terry Doyle TELUS Global Ventures (TGV) Mike Titkov #HealthcareInnovation #PreventiveHealth #DigitalTwin #MRI #AI #SeriesAFunding #QBio #PersonalizedHealth #HealthcareRevolution Read more about this exciting development in STAT's latest article linked in the post below.